annual operating expenses:
$2.27B+$138.23M(+6.49%)Summary
- As of today (September 1, 2025), JAZZ annual total operating expenses is $2.27 billion, with the most recent change of +$138.23 million (+6.49%) on December 31, 2024.
- During the last 3 years, JAZZ annual operating expenses has risen by +$540.86 million (+31.29%).
- JAZZ annual operating expenses is now at all-time high.
Performance
JAZZ Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$548.37M-$146.29M(-21.06%)Summary
- As of today (September 1, 2025), JAZZ quarterly total operating expenses is $548.37 million, with the most recent change of -$146.29 million (-21.06%) on June 30, 2025.
- Over the past year, JAZZ quarterly operating expenses has dropped by -$10.89 million (-1.95%).
- JAZZ quarterly operating expenses is now -21.06% below its all-time high of $694.66 million, reached on March 31, 2025.
Performance
JAZZ quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
JAZZ Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.5% | -1.9% |
| 3 y3 years | +31.3% | +18.0% |
| 5 y5 years | +118.9% | +102.8% |
JAZZ Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.3% | -21.1% | +18.0% |
| 5 y | 5-year | at high | +118.9% | -21.1% | +102.8% |
| alltime | all time | at high | +8860.7% | -21.1% | +2488.1% |
JAZZ Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $548.37M(-21.1%) |
| Mar 2025 | - | $694.66M(+13.9%) |
| Dec 2024 | $2.27B(+6.5%) | $609.79M(+16.0%) |
| Sep 2024 | - | $525.69M(-6.0%) |
| Jun 2024 | - | $559.26M(-2.7%) |
| Mar 2024 | - | $574.56M(+4.3%) |
| Dec 2023 | $2.13B(+18.4%) | $550.91M(+1.5%) |
| Sep 2023 | - | $542.71M(-1.3%) |
| Jun 2023 | - | $550.08M(+12.9%) |
| Mar 2023 | - | $487.33M(-12.3%) |
| Dec 2022 | $1.80B(+4.1%) | $555.76M(+9.2%) |
| Sep 2022 | - | $508.90M(+9.5%) |
| Jun 2022 | - | $464.71M(+5.9%) |
| Mar 2022 | - | $438.79M(-15.0%) |
| Dec 2021 | $1.73B(+45.3%) | $516.11M(+14.4%) |
| Sep 2021 | - | $451.32M(+4.4%) |
| Jun 2021 | - | $432.23M(+28.2%) |
| Mar 2021 | - | $337.08M(-0.5%) |
| Dec 2020 | $1.19B(+14.8%) | $338.87M(+18.5%) |
| Sep 2020 | - | $285.90M(+5.8%) |
| Jun 2020 | - | $270.33M(-8.2%) |
| Mar 2020 | - | $294.51M(-5.5%) |
| Dec 2019 | $1.04B(+14.0%) | $311.66M(+20.5%) |
| Sep 2019 | - | $258.56M(+8.5%) |
| Jun 2019 | - | $238.40M(+4.5%) |
| Mar 2019 | - | $228.05M(+4.4%) |
| Dec 2018 | $909.65M(+22.5%) | $218.52M(+5.5%) |
| Sep 2018 | - | $207.03M(-3.6%) |
| Jun 2018 | - | $214.71M(-20.4%) |
| Mar 2018 | - | $269.88M(+29.1%) |
| Dec 2017 | $742.60M(+13.6%) | $209.04M(+21.6%) |
| Sep 2017 | - | $171.88M(-0.3%) |
| Jun 2017 | - | $172.49M(-8.8%) |
| Mar 2017 | - | $189.18M(+17.3%) |
| Dec 2016 | $653.69M(+12.2%) | $161.32M(-6.3%) |
| Sep 2016 | - | $172.16M(+6.5%) |
| Jun 2016 | - | $161.71M(+1.1%) |
| Mar 2016 | - | $160.02M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $582.53M(+23.4%) | $153.92M(-0.6%) |
| Sep 2015 | - | $154.83M(+14.7%) |
| Jun 2015 | - | $134.97M(-2.7%) |
| Mar 2015 | - | $138.66M(+6.5%) |
| Dec 2014 | $472.05M(+43.9%) | $130.25M(+12.7%) |
| Sep 2014 | - | $115.62M(-1.5%) |
| Jun 2014 | - | $117.35M(+2.5%) |
| Mar 2014 | - | $114.47M(+29.5%) |
| Dec 2013 | $328.03M(+52.0%) | $88.41M(+6.9%) |
| Sep 2013 | - | $82.67M(+0.7%) |
| Jun 2013 | - | $82.14M(+12.1%) |
| Mar 2013 | - | $73.26M(+40.5%) |
| Dec 2012 | $215.75M(+92.9%) | $52.13M(-23.3%) |
| Sep 2012 | - | $67.94M(+7.9%) |
| Jun 2012 | - | $62.96M(+29.7%) |
| Mar 2012 | - | $48.56M(+38.9%) |
| Dec 2011 | $111.86M(+18.2%) | $34.95M(+25.6%) |
| Sep 2011 | - | $27.83M(+9.2%) |
| Jun 2011 | - | $25.48M(+7.9%) |
| Mar 2011 | - | $23.61M(+11.4%) |
| Dec 2010 | $94.61M(-0.6%) | $21.19M(-16.4%) |
| Sep 2010 | - | $25.36M(+1.2%) |
| Jun 2010 | - | $25.06M(+8.9%) |
| Mar 2010 | - | $23.00M(+4.4%) |
| Dec 2009 | $95.21M(-46.5%) | $22.04M(-3.0%) |
| Sep 2009 | - | $22.70M(-8.6%) |
| Jun 2009 | - | $24.85M(-3.0%) |
| Mar 2009 | - | $25.62M(-19.4%) |
| Dec 2008 | $177.86M(+19.9%) | $31.81M(-12.9%) |
| Sep 2008 | - | $36.50M(-34.3%) |
| Jun 2008 | - | $55.53M(+2.8%) |
| Mar 2008 | - | $54.02M(+11.4%) |
| Dec 2007 | $148.33M(+39.5%) | $48.50M(+38.4%) |
| Sep 2007 | - | $35.05M(-1.5%) |
| Jun 2007 | - | $35.58M(+21.8%) |
| Mar 2007 | - | $29.21M |
| Dec 2006 | $106.34M(+53.4%) | - |
| Dec 2005 | $69.33M(+173.8%) | - |
| Dec 2004 | $25.32M | - |
FAQ
- What is Jazz Pharmaceuticals plc annual total operating expenses?
- What is the all time high annual operating expenses for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc annual operating expenses year-on-year change?
- What is Jazz Pharmaceuticals plc quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc quarterly operating expenses year-on-year change?
What is Jazz Pharmaceuticals plc annual total operating expenses?
The current annual operating expenses of JAZZ is $2.27B
What is the all time high annual operating expenses for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual total operating expenses is $2.27B
What is Jazz Pharmaceuticals plc annual operating expenses year-on-year change?
Over the past year, JAZZ annual total operating expenses has changed by +$138.23M (+6.49%)
What is Jazz Pharmaceuticals plc quarterly total operating expenses?
The current quarterly operating expenses of JAZZ is $548.37M
What is the all time high quarterly operating expenses for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly total operating expenses is $694.66M
What is Jazz Pharmaceuticals plc quarterly operating expenses year-on-year change?
Over the past year, JAZZ quarterly total operating expenses has changed by -$10.89M (-1.95%)